Improving cardiometabolic health for people living with HIV in the Southeastern US
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for Persons Living With HIV in the Southeastern United States
This study is trying to find out what challenges people living with HIV face in managing heart and metabolic health so they can create better support and education for those aged 35 and older with these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Duke University Academic / other |
| Locations | 2 sites (Charlotte, North Carolina and 1 other locations) |
| Trial ID | NCT05129345 on ClinicalTrials.gov |
What this trial studies
This observational study aims to address barriers to achieving treatment goals for cardiometabolic disorders among people living with HIV (PLWH) in the Southeastern United States. It consists of three main aims: first, to identify social determinants and barriers affecting cardiometabolic health through in-depth interviews and photo elicitation; second, to assess the knowledge, skills, and confidence of PLWH in managing their conditions; and third, to tailor a self-management support and education intervention based on stakeholder input. The study will involve participants aged 35 and older with at least one cardiometabolic disorder and will utilize a human-centered design approach to develop effective interventions.
Who should consider this trial
Good fit: Ideal candidates are people living with HIV aged 35 and older who have hypertension, dyslipidemia, or type 2 diabetes.
Not a fit: Patients who do not understand English or are blind may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved self-management and health outcomes for PLWH with cardiometabolic disorders.
How similar studies have performed: Other studies have shown success in using tailored interventions for chronic disease management, suggesting potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Aims 1 and 2 * People living with HIV who are at least 35 years of age and who have one or more of the following conditions: hypertension, dyslipidemia, or type 2 diabetes. Aim 3 * Participants recruited from the participating clinics and community based organizations and may include, HIV providers, nurses, pharmacists, people living with HIV who have cardiometabolic disorders, and representatives of the community advisory boards, and any other key stakeholders. Age 18 or older. Exclusion Criteria: * Those who don't understand English and those who are blind.
Where this trial is running
Charlotte, North Carolina and 1 other locations
- Duke University - Charlotte Study Sites — Charlotte, North Carolina, United States (Recruiting)
- Duke University - Duke Study Site — Durham, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Charles Muiruri, PhD — Duke University
- Study coordinator: Stuart T Carr, BA
- Email: stuart.carr@duke.edu
- Phone: 919 668-4849
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.